Contact this trialFirst, we need to learn more about you.
Alkylating agents
Chemoimmunotherapy + Vaccines for Recurrent Ovarian Cancer
Recruiting1 awardPhase 1 & 2
Pittsburgh, Pennsylvania
This trial will test a treatment plan for advanced ovarian cancer patients. They will first receive a combination of drugs directly into the abdominal cavity and through the vein. Then, they will receive another treatment containing a
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service